Nanoparticle Based Cardiac Specific Drug Delivery
Biology · 04.01.2023 · 12 (1) · 82
DOI: 10.3390/biology12010082 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biology, online erschienen am 04.01.2023. Verfasst von Dong Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Diseases, Physiology and Biomedical Engineering, Center for Regenerative Medicine, Mayo Clinic Arizona, Scottsdale, AZ 8…. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: American Heart Association.
Abstract (Originalsprache)
Heart failure secondary to myocardial injuries is a leading cause of death worldwide. Recently, a growing number of novel therapies have emerged for injured myocardium repairment. However, delivering therapeutic agents specifically to the injured heart remains a significant challenge. Nanoparticles are the most commonly used vehicles for targeted drug delivery. Various nanoparticles have been synthesized to deliver drugs and other therapeutic molecules to the injured heart via passive or active targeting approaches, and their targeting specificity and therapeutic efficacies have been investigated. Here, we summarized nanoparticle-based, cardiac-specific drug delivery systems, their potency for treating heart diseases, and the mechanisms underlying these cardiac-targeting strategies. We also discussed the clinical studies that have employed nanoparticle-based cardiac-specific drug delivery.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Diseases, Physiology and Biomedical Engineering, Center for Regenerative Medicine, Mayo Clinic Arizona, Scottsdale, AZ 85259, USA.
- Department of Cardiology, Dongfang Hospital, The Second Affiliated Hospital of Beijing University of Chinese Medicine, Beijing 100078, China.
- Ira A. Fulton Schools of Engineering, Arizona State University, Tempe, AZ 85281, USA.
- College of Health Solutions, Arizona State University, Phoenix, AZ 85004, USA.
ORCID-Profile: Yura Son, Shu Wang, Wuqiang Zhu
Förderung
- American Heart Association
Zitieren
APA
Li, D., Son, Y., Jang, M., Wang, S., & Zhu, W. (2023). Nanoparticle Based Cardiac Specific Drug Delivery. Biology, 12(1), 82. https://doi.org/10.3390/biology12010082
Vancouver
Li D, Son Y, Jang M, Wang S, Zhu W. Nanoparticle Based Cardiac Specific Drug Delivery. Biology. 2023;12(1):82. doi:10.3390/biology12010082
BibTeX
@article{Li2023,
author = {Li, Dong and Son, Yura and Jang, Michelle and Wang, Shu and Zhu, Wuqiang},
title = {Nanoparticle Based Cardiac Specific Drug Delivery},
journal = {Biology},
year = {2023},
volume = {12},
number = {1},
pages = {82},
doi = {10.3390/biology12010082}
}
EUVIMED